← SynDRA
GIVINOSTAT
SynDRA canonical compound SYN0023775 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | HDAC2 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
All known targets
- HDAC1
- HDAC2
- HDAC3
- HDAC4
- HDAC5
- HDAC6
- HDAC7
- HDAC8
- HDAC9
- HDAC10
- HDAC11
- IL1B
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC1 INHIBITOR
- HDAC3 INHIBITOR
- HDAC6 INHIBITOR
- HDAC2 INHIBITOR
- HDAC5 INHIBITOR
- HDAC7 INHIBITOR
- HDAC8 INHIBITOR
- HDAC11 INHIBITOR
- HDAC4 INHIBITOR
- HDAC9 INHIBITOR
- HDAC10 INHIBITOR
Drug classes
- Histone Deacetylase Inhibitors
ATC classes
- M09A · OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
Cross-references
Synonyms
- ITF-2357
- ITF2357
- Carbamic acid, N-(4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl ester, hydrochloride (1:1)
- Givinostat [INN]
- Givinostat free base
- [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
- 5P60F84FBH
- CHEMBL1213492
- 497833-27-9 (free base)
- (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate
- (6-((Diethylamino)methyl)naphthalen-2-yl)methyl(4-(hydroxycarbamoyl)phenyl)carbamate
- [4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester
- Gavinostat
- 4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester
- UNII-5P60F84FBH
- {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate
- Gavinostat;ITF-2357
- GTPL7490
- SCHEMBL1555814
- CHEBI:94187
- DTXSID70198049
- BCP29856
- ZINC3820616
- BDBM50105329
- CS-4727
- DB12645
- EX-5958
- [6-(diethylaminomethyl)-2-naphthyl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
- AC-31380
- BCB04_000011
- HY-14842
- EC-000.2471
- EN300-260030
- 833H279
- A923985
- Q426257
- Gavinostat; ITF-2357; ITF2357; ITF 2357
- BRD-K13810148-001-01-3
Look up GIVINOSTAT in the interactive SynDRA portal →